1. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. Issue 10 (7th October 2022) Authors: Sriranjan, Rouchelle; Zhao, Tian Xiao; Tarkin, Jason; Hubsch, Annette; Helmy, Joanna; Vamvaka, Evangelia; Jalaludeen, Navazh; Bond, Simon; Hoole, Stephen P; Knott, Philip; Buckenham, Samantha; Warnes, Victoria; Bird, Nick; Cheow, Heok; Templin, Heike; Cacciottolo, Paul; Rudd, James H F; Mallat, Z... Journal: BMJ open Issue: Volume 12:Issue 10(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗